A Study of the Survival Rate of Childhood Cancer in Korea

Insights

This study reports the 5-year survival rates for major childhood cancers in Korea (1993-1997). The overall survival rate was 62%, with significant variations among specific pediatric cancer types.

Area of Science:

  • Pediatric Oncology
  • Cancer Epidemiology
  • Biostatistics

Background:

  • Childhood cancer prognosis is generally good, but representative nationwide survival data are scarce.
  • Establishing accurate survival rates is crucial for understanding disease burden and improving outcomes.

Purpose of the Study:

  • To determine the overall and specific 5-year survival rates for major childhood cancers in Korea.
  • To provide essential statistical data for pediatric cancer research and public health initiatives.

Main Methods:

  • Utilized registry data from the Central Cancer Registry (1993-1997) for children under 15.
  • Cross-referenced with death certificate data from the Korea National Statistical Office using personal identification codes.
  • Calculated survival rates using Kaplan-Meier and life table methods via SPSS software.

Main Results:

  • Analyzed 4,983 confirmed pediatric cancer cases; 29.1% resulted in death.
  • Leukemia was the most common (29%), followed by brain tumors (10%) and lymphoma (6%).
  • Overall 5-year survival was 62%; specific rates included Wilms tumor (83%), malignant lymphoma (72%), and acute lymphocytic leukemia (61%).

Conclusions:

  • Presents the first comprehensive 5-year survival data for major childhood cancers in Korea (1993-1997).
  • Highlights significant survival disparities among different pediatric cancer types.
  • Provides foundational data for future childhood cancer statistics and clinical management.
Abstract

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
827
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
719
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.3K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
704